Inhibitory effects of arbutin on melanin biosynthesis of α-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues

Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; there...

Full description

Saved in:
Bibliographic Details
Published inArchives of pharmacal research Vol. 32; no. 3; pp. 367 - 373
Main Authors Lim, Yu-Ji, Lee, Eunjoo H., Kang, Tong Ho, Ha, Sang Keun, Oh, Myung Sook, Kim, Seong Min, Yoon, Tae-Jin, Kang, Chulhun, Park, Ji-Ho, Kim, Sun Yeou
Format Journal Article
LanguageEnglish
Published Heidelberg Pharmaceutical Society of Korea 01.03.2009
대한약학회
Subjects
Online AccessGet full text
ISSN0253-6269
1976-3786
DOI10.1007/s12272-009-1309-8

Cover

Abstract Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with α-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of α-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening.
AbstractList Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with alpha-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of alpha-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening.Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with alpha-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of alpha-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening.
Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with α-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of α-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening.
Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with alpha-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of alpha-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening.
Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or in conditions such as melasma or hyperpigmentary diseases. Tyrosinase is a key enzyme that catalyzes melanin synthesis in melanocytes; therefore, inhibitors of the tyrosinase enzyme could be used for cosmetic skin whitening. A recent study has reported that arbutin decreases melanin biosynthesis through the inhibition of tyrosinase activity. However, this inhibitory mechanism of arbutin was not sufficiently demonstrated in skin tissue models. We found that arbutin both inhibits melanin production in B16 cells induced with α-MSH and decreases tyrosinase activity in a cell-free system. Furthermore, the hyperpigmentation effects of α-MSH were abrogated by the addition of arbutin to brownish guinea pig and human skin tissues. These results suggest that arbutin may be a useful agent for skin whitening. KCI Citation Count: 112
Author Ha, Sang Keun
Kim, Sun Yeou
Lim, Yu-Ji
Park, Ji-Ho
Kim, Seong Min
Yoon, Tae-Jin
Kang, Chulhun
Lee, Eunjoo H.
Oh, Myung Sook
Kang, Tong Ho
Author_xml – sequence: 1
  givenname: Yu-Ji
  surname: Lim
  fullname: Lim, Yu-Ji
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University
– sequence: 2
  givenname: Eunjoo H.
  surname: Lee
  fullname: Lee, Eunjoo H.
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University
– sequence: 3
  givenname: Tong Ho
  surname: Kang
  fullname: Kang, Tong Ho
  organization: Department of Oriental Medicinal Materials and Processing, College of Life Sciences, Kyung Hee University
– sequence: 4
  givenname: Sang Keun
  surname: Ha
  fullname: Ha, Sang Keun
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University
– sequence: 5
  givenname: Myung Sook
  surname: Oh
  fullname: Oh, Myung Sook
  organization: Department of Oriental Pharmaceutical Science and Kyung Hee East-West Pharmaceutical Research Institute, College of Pharmacy, Kyung Hee University
– sequence: 6
  givenname: Seong Min
  surname: Kim
  fullname: Kim, Seong Min
  organization: Department of Dermatology, School of Medicine, Gyeongsang National University
– sequence: 7
  givenname: Tae-Jin
  surname: Yoon
  fullname: Yoon, Tae-Jin
  organization: Department of Dermatology, School of Medicine, Gyeongsang National University
– sequence: 8
  givenname: Chulhun
  surname: Kang
  fullname: Kang, Chulhun
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University
– sequence: 9
  givenname: Ji-Ho
  surname: Park
  fullname: Park, Ji-Ho
  email: jihopark@khu.ac.kr
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University
– sequence: 10
  givenname: Sun Yeou
  surname: Kim
  fullname: Kim, Sun Yeou
  email: sunnykim@khu.ac.kr
  organization: Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University, Skin Biotechnology Research Center, Kyung Hee University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19387580$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001336130$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kc9q3DAQxkVJaTZpH6CXolMhB7eStZbsYwj9sxAolPQsJHlsK2tLW0km-HH6CH2RPFO165RCD7loxMzvmxnmu0BnzjtA6C0lHygh4mOkZSnKgpCmoCw_9Qu0oY3gBRM1P0MbUlas4CVvztFFjPeEMF5V1St0ThtWi6omG_Rr5warbfJhwdB1YFLEvsMq6DlZh73DE4zK5a-2Pi4uDRDtCXn8XZxK3iwJcEx2mkeVNT0efJjyooV17WygxcNygHCw_QQuZSL3zO3MPKY55KoO_sHZOOB-tg4UziCO-0wkG-MM8TV62akxwpuneIl-fP50d_O1uP32ZXdzfVsYJngqtk0JpiGaQguihVq3omu2pWprrQ3jGljX8aoljLFK0VYJw8DkjGgph23F2CW6Wvu60Mm9sdIre4q9l_sgr7_f7SSlrKZVndn3K3sI_mfeMcnJRgNjPgf4OUouaMVZSTL47gmc9QStPAQ7qbDIvwZkgK6ACT7GAN0_hMijyXI1WWaT5dFkeZwu_tMYux42BWXHZ5Xlqox5iushyHs_B5fP-ozoDzWWwRg
CitedBy_id crossref_primary_10_3390_microorganisms12010188
crossref_primary_10_1007_s11274_023_03853_4
crossref_primary_10_22159_ijhs_2023_v11i1_49554
crossref_primary_10_5625_lar_2010_26_2_127
crossref_primary_10_3136_fstr_20_505
crossref_primary_10_1007_s10495_014_1032_x
crossref_primary_10_1080_21691401_2019_1640231
crossref_primary_10_1096_fj_14_256305
crossref_primary_10_1038_s41598_020_76376_9
crossref_primary_10_1211_jpp_62_03_0010
crossref_primary_10_3390_plants11070873
crossref_primary_10_1002_cbdv_201300182
crossref_primary_10_1016_j_gene_2018_02_060
crossref_primary_10_1002_cbdv_201300181
crossref_primary_10_1016_j_jff_2016_01_031
crossref_primary_10_12677_acm_2025_152439
crossref_primary_10_1016_j_jff_2015_05_022
crossref_primary_10_5650_jos_ess15047
crossref_primary_10_3390_pr10050855
crossref_primary_10_1111_jocd_13344
crossref_primary_10_5650_jos_59_213
crossref_primary_10_3390_antiox10071129
crossref_primary_10_1002_cbdv_201300348
crossref_primary_10_1016_j_mrgentox_2021_503413
crossref_primary_10_3390_antiox11030502
crossref_primary_10_1007_s13410_021_00920_0
crossref_primary_10_1016_j_bcp_2019_04_015
crossref_primary_10_17706_ijbbb_2019_9_3_188_193
crossref_primary_10_1007_s13273_016_0022_1
crossref_primary_10_1016_j_lfs_2023_121612
crossref_primary_10_1007_s12257_014_0415_8
crossref_primary_10_1021_acs_biomac_3c00123
crossref_primary_10_1007_s00403_018_1820_1
crossref_primary_10_48022_mbl_2303_03012
crossref_primary_10_1021_acs_jafc_2c07972
crossref_primary_10_3839_jabc_2022_030
crossref_primary_10_1016_j_phymed_2014_06_009
crossref_primary_10_20307_nps_2023_29_2_59
crossref_primary_10_1016_j_bioorg_2020_103941
crossref_primary_10_1002_2211_5463_13024
crossref_primary_10_1016_j_ijbiomac_2016_01_098
crossref_primary_10_1016_j_phytol_2015_05_015
crossref_primary_10_1186_s12906_020_02989_2
crossref_primary_10_1371_journal_pone_0177330
crossref_primary_10_1080_14786419_2019_1667346
crossref_primary_10_1002_cbdv_201400424
crossref_primary_10_1016_j_fitote_2020_104634
crossref_primary_10_1002_cbdv_201200111
crossref_primary_10_1248_bpb_b17_01045
crossref_primary_10_4062_biomolther_2014_031
crossref_primary_10_5650_jos_59_49
crossref_primary_10_1002_cbdv_201200357
crossref_primary_10_1007_s11101_024_10048_8
crossref_primary_10_5650_jos_58_581
crossref_primary_10_1016_j_fct_2011_09_008
crossref_primary_10_1111_jocd_12900
crossref_primary_10_3390_ijms19092825
crossref_primary_10_3892_mmr_2019_10125
crossref_primary_10_2174_2666779702666230731161153
crossref_primary_10_2174_2589977514666220321114415
crossref_primary_10_4236_jcdsa_2012_23030
crossref_primary_10_5012_bkcs_2014_35_10_3085
crossref_primary_10_1002_cbdv_201200024
crossref_primary_10_3892_ijmm_2024_5454
crossref_primary_10_1186_s10020_024_00957_x
crossref_primary_10_3390_molecules19032808
crossref_primary_10_3390_molecules25235555
crossref_primary_10_1002_cbdv_201600100
crossref_primary_10_3390_md20020123
crossref_primary_10_1111_jocd_12979
crossref_primary_10_1039_D3BM00132F
crossref_primary_10_3390_molecules18055568
crossref_primary_10_1002_cbdv_201300149
crossref_primary_10_1002_ejoc_202100672
crossref_primary_10_1186_s41240_018_0112_1
crossref_primary_10_1002_cbdv_201300266
crossref_primary_10_1016_j_heliyon_2023_e22421
crossref_primary_10_3390_ph17101343
crossref_primary_10_1002_cbdv_201200251
crossref_primary_10_1007_s13659_022_00363_y
crossref_primary_10_1016_j_phytochem_2014_09_017
crossref_primary_10_3390_cosmetics11020043
crossref_primary_10_1002_jsfa_7155
crossref_primary_10_3390_plants12010083
crossref_primary_10_5650_jos_60_53
crossref_primary_10_1080_14786419_2017_1359169
crossref_primary_10_1016_j_semcdb_2013_03_015
crossref_primary_10_3390_biomedicines11061563
crossref_primary_10_3109_09637486_2010_523416
crossref_primary_10_1007_s10068_013_0236_0
crossref_primary_10_1007_s12033_022_00516_x
crossref_primary_10_1016_j_bmcl_2020_127276
crossref_primary_10_12677_HJFNS_2019_81005
crossref_primary_10_1016_j_jfca_2018_04_010
crossref_primary_10_1002_ptr_7076
crossref_primary_10_1007_s11655_025_3827_8
crossref_primary_10_3390_molecules19044802
crossref_primary_10_1002_cbdv_201100350
crossref_primary_10_1177_15353702211002136
crossref_primary_10_3390_antiox9030258
crossref_primary_10_1021_acs_jnatprod_7b00056
crossref_primary_10_3363_prb_33_21
crossref_primary_10_1177_1934578X1300801006
crossref_primary_10_1016_j_jdermsci_2018_04_011
crossref_primary_10_1080_17425247_2023_2206645
crossref_primary_10_1016_j_jgr_2017_03_007
crossref_primary_10_1007_s10616_024_00657_8
crossref_primary_10_1016_j_bmc_2016_09_054
crossref_primary_10_1016_j_intimp_2013_11_028
crossref_primary_10_1016_j_jphotobiol_2025_113100
crossref_primary_10_1093_plcell_koae140
crossref_primary_10_1080_14786419_2017_1292270
crossref_primary_10_1111_jocd_12354
crossref_primary_10_1002_cbdv_201100349
crossref_primary_10_1002_cbdv_201600247
crossref_primary_10_1016_j_jdermsci_2017_05_019
crossref_primary_10_1016_j_jgr_2016_12_009
crossref_primary_10_1016_j_eujim_2018_10_013
crossref_primary_10_1080_00032719_2015_1022825
crossref_primary_10_1002_cbdv_201700105
crossref_primary_10_1016_j_bbrc_2018_12_105
crossref_primary_10_1080_15287394_2024_2393308
crossref_primary_10_1177_1934578X1701200422
crossref_primary_10_1016_j_foodchem_2011_12_049
crossref_primary_10_1002_cbdv_201300406
crossref_primary_10_1002_cbdv_201200030
Cites_doi 10.1111/1523-1747.ep12581579
10.1159/000081503
10.1074/jbc.R700026200
10.1046/j.1365-3164.2003.00327.x
10.1111/j.1749-6632.1999.tb08679.x
10.1002/ptr.1456
10.1007/s11010-005-1081-0
10.1034/j.1600-0749.2001.140106.x
10.1248/bpb.28.323
10.1034/j.1600-0749.2003.00029.x
10.1111/j.1600-0749.1998.tb00705.x
10.1006/abio.1999.4090
10.1248/bpb.28.838
10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I
10.1248/cpb.51.798
10.1111/j.1600-0749.2004.00183.x
10.1016/j.bmc.2006.12.042
10.1248/bpb.27.510
10.1046/j.0022-202x.2001.01668.x
10.1034/j.1600-0625.12.s2.7.x
10.1248/bpb.29.1947
10.1248/bpb.30.180
10.1073/pnas.85.11.3830
10.1038/emm.2001.23
ContentType Journal Article
Copyright The Pharmaceutical Society of Korea 2009
Copyright_xml – notice: The Pharmaceutical Society of Korea 2009
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ACYCR
DOI 10.1007/s12272-009-1309-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1976-3786
EndPage 373
ExternalDocumentID oai_kci_go_kr_ARTI_1138158
19387580
10_1007_s12272_009_1309_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-53
-56
-5G
-BR
-EM
-Y2
-~C
.86
.UV
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2WC
2~H
30V
3SX
4.4
406
408
40D
40E
53G
5GY
5VS
67N
67Z
6J9
6NX
8TC
8UJ
95-
95.
95~
96X
9ZL
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACUDM
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
KVFHK
LLZTM
M4Y
MA-
MZR
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDE
SDH
SHX
SISQX
SJN
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z83
Z87
Z8O
Z8P
Z8Q
Z91
ZMTXR
ZOVNA
ZZE
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AABYN
AAFGU
AAKSU
AAYFA
ABFGW
ABKAS
ACBMV
ACBRV
ACBYP
ACIGE
ACIPQ
ACTTH
ACVWB
ACWMK
ACYCR
ADMDM
ADOXG
AEEQQ
AEFTE
AESTI
AEVTX
AFAFS
AFNRJ
AGGBP
AGKHE
AIMYW
AJDOV
AKQUC
UNUBA
Z7X
ID FETCH-LOGICAL-c376t-492ec90b1ede7de8bd7f942ad8bbc36be3ff65d03335a1da7c3ecf657d16e4533
IEDL.DBID U2A
ISSN 0253-6269
IngestDate Sun Dec 31 10:50:42 EST 2023
Wed Oct 01 13:43:14 EDT 2025
Wed Feb 19 01:45:03 EST 2025
Thu Apr 24 23:04:29 EDT 2025
Wed Oct 01 04:24:45 EDT 2025
Fri Feb 21 02:37:07 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords TRP-1
TRP-2
Skin tissue culture
Melanocyte
Melanogenesis
α-MSH
Arbutin
Hyperpigmentation
Melanin
Tyrosinase
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c376t-492ec90b1ede7de8bd7f942ad8bbc36be3ff65d03335a1da7c3ecf657d16e4533
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000010.2009.32.3.006
PMID 19387580
PQID 67156320
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1138158
proquest_miscellaneous_67156320
pubmed_primary_19387580
crossref_primary_10_1007_s12272_009_1309_8
crossref_citationtrail_10_1007_s12272_009_1309_8
springer_journals_10_1007_s12272_009_1309_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20090300
2009-3-00
2009-Mar
20090301
2009-03
PublicationDateYYYYMMDD 2009-03-01
PublicationDate_xml – month: 3
  year: 2009
  text: 20090300
PublicationDecade 2000
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: Korea (South)
PublicationTitle Archives of pharmacal research
PublicationTitleAbbrev Arch. Pharm. Res
PublicationTitleAlternate Arch Pharm Res
PublicationYear 2009
Publisher Pharmaceutical Society of Korea
대한약학회
Publisher_xml – name: Pharmaceutical Society of Korea
– name: 대한약학회
References Thody (CR21) 1999; 885
Tobiishi, Haratake, Kaminaga, Nakahara, Komiya, Koishikawa, Uchiwa, Kawa, Mizoguchi (CR22) 2004; 17
Boisnic, Branchet-Gumila, Nocera, Verriere (CR2) 2005; 210
Sugimoto, Nishimura, Nomura, Sugimoto, Kuriki (CR18) 2004; 27
Hosoi, Abe, Suda, Kuroki (CR7) 1985; 45
Akiu, Suzuki, Asahara, Fujinuma, Fukuda (CR1) 1991; 101
Sugimoto, Nishimura, Nomura, Sugimoto, Kuriki (CR17) 2003; 51
Briganti, Camera, Picardo (CR3) 2003; 16
Hori, Nihei, Kubo (CR6) 2004; 18
Usuki, Ohashi, Sato, Ochiai, Ichihashi, Funasaka (CR24) 2003; 12
Ha, Koketsu, Lee, Choi, Park, Ishihara, Kim (CR5) 2005; 28
Schwahn, Xu, Herrin, Bales, Medrano (CR15) 2001; 14
Ohguchi, Akao, Nozawa (CR14) 2005; 275
Jimenez, Kameyama, Maloy, Tomita, Hearing (CR8) 1988; 85
Maeda, Fukuda (CR12) 1996; 276
Grabe (CR4) 1968
Tammi, Jansen, Santti (CR20) 1979; 73
Jung, Yang, Song, Par (CR9) 2001; 33
Kim, Jeong, Park (CR10) 2007; 30
Tsuji-Naito, Hatani, Okada, Tehara (CR23) 2007; 15
Sulaimon, Kitchell (CR19) 2003; 14
Zhong, Wu, Soo-Mi, Zhao, Wang, Yang, Jae-Ho, Zhu (CR28) 2006; 29
Nakajima, Shinoda, Fukuwatari, Hayasawa (CR13) 1998; 11
Yamaguchi, Brenner, Hearing (CR26) 2007; 282
Kim, No, Lee, Chung (CR11) 2005; 28
Yoshida, Hirotsu, Nakahara, Uchiwa, Tomita (CR27) 2002; 118
Virador, Kobayashi, Matsunaga, Hearing (CR25) 1999; 270
Sturm, Box, Ramsay (CR16) 1998; 20
Y. Yamaguchi (1309_CR26) 2007; 282
J. Hosoi (1309_CR7) 1985; 45
V. M. Virador (1309_CR25) 1999; 270
K. Ohguchi (1309_CR14) 2005; 275
K. Tsuji-Naito (1309_CR23) 2007; 15
Y. J. Kim (1309_CR11) 2005; 28
S. Akiu (1309_CR1) 1991; 101
A. Usuki (1309_CR24) 2003; 12
G. D. Jung (1309_CR9) 2001; 33
R. Tammi (1309_CR20) 1979; 73
M. Yoshida (1309_CR27) 2002; 118
M. Grabe (1309_CR4) 1968
K. Maeda (1309_CR12) 1996; 276
S. Boisnic (1309_CR2) 2005; 210
M. Jimenez (1309_CR8) 1988; 85
D. J. Schwahn (1309_CR15) 2001; 14
S. Zhong (1309_CR28) 2006; 29
A. J. Thody (1309_CR21) 1999; 885
R. A. Sturm (1309_CR16) 1998; 20
K. Sugimoto (1309_CR17) 2003; 51
D. S. Kim (1309_CR10) 2007; 30
M. Nakajima (1309_CR13) 1998; 11
I. Hori (1309_CR6) 2004; 18
K. Sugimoto (1309_CR18) 2004; 27
M. Tobiishi (1309_CR22) 2004; 17
S. K. Ha (1309_CR5) 2005; 28
S. S. Sulaimon (1309_CR19) 2003; 14
S. Briganti (1309_CR3) 2003; 16
References_xml – volume: 45
  start-page: 1474
  year: 1985
  end-page: 1478
  ident: CR7
  article-title: Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid
  publication-title: Cancer. Res.
– volume: 73
  start-page: 138
  year: 1979
  end-page: 140
  ident: CR20
  article-title: Histometric analysis of human skin in organ culture
  publication-title: J. Invest. Dermatol.
  doi: 10.1111/1523-1747.ep12581579
– volume: 210
  start-page: 35
  issue: Suppl1
  year: 2005
  end-page: 38
  ident: CR2
  article-title: RALGA (Diacneal) decreases melanin content in a human skin model
  publication-title: Dermatology.
  doi: 10.1159/000081503
– volume: 282
  start-page: 27557
  year: 2007
  end-page: 27561
  ident: CR26
  article-title: The regulation of skin pigmentation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R700026200
– volume: 14
  start-page: 57
  year: 2003
  end-page: 65
  ident: CR19
  article-title: The biology of melanocytes
  publication-title: Vet. Dermatol.
  doi: 10.1046/j.1365-3164.2003.00327.x
– volume: 101
  start-page: 609
  year: 1991
  end-page: 613
  ident: CR1
  article-title: Inhibitory effect of arbutin on melanogenesis-biochemical study using cultured B16 melanoma cells
  publication-title: Nippon. Hifuka. Gakkai. Zasshi.
– volume: 885
  start-page: 217
  year: 1999
  end-page: 229
  ident: CR21
  article-title: alpha-MSH and the regulation of melanocyte function
  publication-title: Ann. N Y Acad. Sci.
  doi: 10.1111/j.1749-6632.1999.tb08679.x
– volume: 18
  start-page: 475
  year: 2004
  end-page: 479
  ident: CR6
  article-title: Structural criteria for depigmenting mechanism of arbutin
  publication-title: Phytother. Res.
  doi: 10.1002/ptr.1456
– volume: 275
  start-page: 103
  year: 2005
  end-page: 107
  ident: CR14
  article-title: Involvement of calpain in melanogenesis of mouse B16 melanoma cells
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-005-1081-0
– volume: 14
  start-page: 32
  year: 2001
  end-page: 39
  ident: CR15
  article-title: Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: Implications for pigmentation and proliferation
  publication-title: Pigment. Cell. Res.
  doi: 10.1034/j.1600-0749.2001.140106.x
– volume: 28
  start-page: 323
  year: 2005
  end-page: 327
  ident: CR11
  article-title: 4,4′-Dihydroxybiphenyl as a new potent tyrosinase inhibitor
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.28.323
– volume: 16
  start-page: 101
  year: 2003
  end-page: 110
  ident: CR3
  article-title: Chemical and instrumental approaches to treat hyperpigmentation
  publication-title: Pigment. Cell. Res.
  doi: 10.1034/j.1600-0749.2003.00029.x
– volume: 33
  start-page: 131
  year: 2001
  end-page: 135
  ident: CR9
  article-title: Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells
  publication-title: Exp. Mol. Med.
– volume: 11
  start-page: 12
  year: 1998
  end-page: 17
  ident: CR13
  article-title: Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity
  publication-title: Pigment. Cell. Res.
  doi: 10.1111/j.1600-0749.1998.tb00705.x
– volume: 276
  start-page: 765
  year: 1996
  end-page: 769
  ident: CR12
  article-title: Arbutin: mechanism of its depigmenting action in human melanocyte culture
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 270
  start-page: 207
  year: 1999
  end-page: 219
  ident: CR25
  article-title: A standardized protocol for assessing regulators of pigmentation
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.1999.4090
– volume: 28
  start-page: 838
  year: 2005
  end-page: 840
  ident: CR5
  article-title: Inhibition of tyrosinase activity by N,N-unsubstituted selenourea derivatives
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.28.838
– volume: 20
  start-page: 712
  year: 1998
  end-page: 721
  ident: CR16
  article-title: Human pigmentation genetics: the difference is only skin deep
  publication-title: Bioessays.
  doi: 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I
– volume: 51
  start-page: 798
  year: 2003
  end-page: 801
  ident: CR17
  article-title: Syntheses of arbutin-alpha-glycosides and a comparison of their inhibitory effects with those of alpha-arbutin and arbutin on human tyrosinase
  publication-title: Chem. Pharm. Bull (Tokyo).
  doi: 10.1248/cpb.51.798
– volume: 17
  start-page: 651
  year: 2004
  end-page: 658
  ident: CR22
  article-title: Pigmentation in intrinsically aged skin of A1 guinea pigs
  publication-title: Pigment. Cell. Res.
  doi: 10.1111/j.1600-0749.2004.00183.x
– volume: 15
  start-page: 1967
  year: 2007
  end-page: 1975
  ident: CR23
  article-title: Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2006.12.042
– volume: 27
  start-page: 510
  year: 2004
  end-page: 514
  ident: CR18
  article-title: Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.27.510
– volume: 118
  start-page: 255
  year: 2002
  end-page: 260
  ident: CR27
  article-title: Histamine is involved in ultraviolet Binduced pigmentation of guinea pig skin
  publication-title: J. Invest. Dermatol.
  doi: 10.1046/j.0022-202x.2001.01668.x
– year: 1968
  ident: CR4
  publication-title: Techniques histologiques
– volume: 12
  start-page: 43
  issue: Suppl2
  year: 2003
  end-page: 50
  ident: CR24
  article-title: The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells
  publication-title: Exp. Dermatol.
  doi: 10.1034/j.1600-0625.12.s2.7.x
– volume: 29
  start-page: 1947
  year: 2006
  end-page: 1951
  ident: CR28
  article-title: Depigmentation of melanocytes by the treatment of extracts from traditional Chinese herbs: a cell culture assay
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.29.1947
– volume: 30
  start-page: 180
  year: 2007
  end-page: 183
  ident: CR10
  article-title: A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.30.180
– volume: 85
  start-page: 3830
  year: 1988
  end-page: 3834
  ident: CR8
  article-title: Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone
  publication-title: Proc. Natl. Acad. Sci USA.
  doi: 10.1073/pnas.85.11.3830
– volume: 45
  start-page: 1474
  year: 1985
  ident: 1309_CR7
  publication-title: Cancer. Res.
– volume: 28
  start-page: 838
  year: 2005
  ident: 1309_CR5
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.28.838
– volume: 17
  start-page: 651
  year: 2004
  ident: 1309_CR22
  publication-title: Pigment. Cell. Res.
  doi: 10.1111/j.1600-0749.2004.00183.x
– volume: 28
  start-page: 323
  year: 2005
  ident: 1309_CR11
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.28.323
– volume: 30
  start-page: 180
  year: 2007
  ident: 1309_CR10
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.30.180
– volume: 27
  start-page: 510
  year: 2004
  ident: 1309_CR18
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.27.510
– volume: 18
  start-page: 475
  year: 2004
  ident: 1309_CR6
  publication-title: Phytother. Res.
  doi: 10.1002/ptr.1456
– volume: 16
  start-page: 101
  year: 2003
  ident: 1309_CR3
  publication-title: Pigment. Cell. Res.
  doi: 10.1034/j.1600-0749.2003.00029.x
– volume: 51
  start-page: 798
  year: 2003
  ident: 1309_CR17
  publication-title: Chem. Pharm. Bull (Tokyo).
  doi: 10.1248/cpb.51.798
– volume: 12
  start-page: 43
  issue: Suppl2
  year: 2003
  ident: 1309_CR24
  publication-title: Exp. Dermatol.
  doi: 10.1034/j.1600-0625.12.s2.7.x
– volume: 210
  start-page: 35
  issue: Suppl1
  year: 2005
  ident: 1309_CR2
  publication-title: Dermatology.
  doi: 10.1159/000081503
– volume: 85
  start-page: 3830
  year: 1988
  ident: 1309_CR8
  publication-title: Proc. Natl. Acad. Sci USA.
  doi: 10.1073/pnas.85.11.3830
– volume: 276
  start-page: 765
  year: 1996
  ident: 1309_CR12
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 73
  start-page: 138
  year: 1979
  ident: 1309_CR20
  publication-title: J. Invest. Dermatol.
  doi: 10.1111/1523-1747.ep12581579
– volume: 101
  start-page: 609
  year: 1991
  ident: 1309_CR1
  publication-title: Nippon. Hifuka. Gakkai. Zasshi.
– volume: 33
  start-page: 131
  year: 2001
  ident: 1309_CR9
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2001.23
– volume: 20
  start-page: 712
  year: 1998
  ident: 1309_CR16
  publication-title: Bioessays.
  doi: 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I
– volume: 11
  start-page: 12
  year: 1998
  ident: 1309_CR13
  publication-title: Pigment. Cell. Res.
  doi: 10.1111/j.1600-0749.1998.tb00705.x
– volume: 885
  start-page: 217
  year: 1999
  ident: 1309_CR21
  publication-title: Ann. N Y Acad. Sci.
  doi: 10.1111/j.1749-6632.1999.tb08679.x
– volume: 14
  start-page: 57
  year: 2003
  ident: 1309_CR19
  publication-title: Vet. Dermatol.
  doi: 10.1046/j.1365-3164.2003.00327.x
– volume: 14
  start-page: 32
  year: 2001
  ident: 1309_CR15
  publication-title: Pigment. Cell. Res.
  doi: 10.1034/j.1600-0749.2001.140106.x
– volume-title: Techniques histologiques
  year: 1968
  ident: 1309_CR4
– volume: 275
  start-page: 103
  year: 2005
  ident: 1309_CR14
  publication-title: Mol. Cell. Biochem.
  doi: 10.1007/s11010-005-1081-0
– volume: 282
  start-page: 27557
  year: 2007
  ident: 1309_CR26
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.R700026200
– volume: 118
  start-page: 255
  year: 2002
  ident: 1309_CR27
  publication-title: J. Invest. Dermatol.
  doi: 10.1046/j.0022-202x.2001.01668.x
– volume: 15
  start-page: 1967
  year: 2007
  ident: 1309_CR23
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2006.12.042
– volume: 29
  start-page: 1947
  year: 2006
  ident: 1309_CR28
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.29.1947
– volume: 270
  start-page: 207
  year: 1999
  ident: 1309_CR25
  publication-title: Anal. Biochem.
  doi: 10.1006/abio.1999.4090
SSID ssj0036555
Score 2.2624857
Snippet Arbutin has been used as a whitening agent in cosmetic products. Melanin, the major pigment that gives color to skin, may be over-produced with sun exposure or...
SourceID nrf
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 367
SubjectTerms Agaricales - enzymology
alpha-MSH - metabolism
Animals
Arbutin - pharmacology
Cell Line, Tumor
Cell Survival - drug effects
Cosmetics - pharmacology
Dermatologic Agents - pharmacology
Dose-Response Relationship, Drug
Enzyme Inhibitors - pharmacology
Female
Guinea Pigs
Humans
Hyperpigmentation - drug therapy
Hyperpigmentation - metabolism
Hyperpigmentation - physiopathology
Medicine
Melanins - biosynthesis
Melanoma, Experimental - enzymology
Melanoma, Experimental - metabolism
Middle Aged
Monophenol Monooxygenase - metabolism
Organ Culture Techniques
Pharmacology/Toxicology
Pharmacy
Skin - drug effects
Skin - enzymology
Skin - metabolism
Skin Pigmentation - drug effects
약학
Title Inhibitory effects of arbutin on melanin biosynthesis of α-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues
URI https://link.springer.com/article/10.1007/s12272-009-1309-8
https://www.ncbi.nlm.nih.gov/pubmed/19387580
https://www.proquest.com/docview/67156320
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001336130
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Archives of Pharmacal Research, 2009, 32(3), , pp.367-373
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AFBBN
  dateStart: 19970201
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NatwwEBZNAqWX0qQ_SX9SUUoObQRey7as4yZkm7Qk5JCF9CQsWdo1m5WD7T3s4_QR-iJ9po5kO6YkLfRkY41lgcaj72OkbxD6mChlJI0NiU0IBMUwRiTwHRIpnscUoiP3EhvnF8npNPp6HV9357jrfrd7n5L0kXo47BaGLCRevt-lBdINtBU7NS9w4mk47sMvTWJf6hTWckoArfM-lflQF38sRhu2Mg_hzHs5Ur_0TJ6hpx1mxON2krfRI2130OPzLiu-gw4uW_3p9SG-Go5T1Yf4AF8OytTr5-jHmZ0XsnB5ddxt5MClwVnlal5ZXFq81DeZhVtZlPXaAjisC2_y6yfxTaVaNxpDWFj6sl92hucAekurCXB78JIcz4HYVrfFbNkdarIYumv1PaBVOtZf1HM8W8HQMwyGuF6AReMdoH6BppOTq-NT0tVoIApCU0MiHmrFAznSuWa5TmXODI_CLE-lVDSRmhqTxHlAKY2zUZ4xRbWCJywfJToCrPkSbVoY5S7CimYRT1SaBQBx5CjlkksWMBYY5foJ9lDQT5ZQnYC5q6NxIwbpZTe_AubXZem4SPfQp7tXblv1jn8ZfwAPEAtVCKe57a6zUiwqAcziDJgSYJsYjN73DiLgR3TZlczqclWLhAEVpiEM81XrN8MXOQVWmELL596RRBcp6r8P5_V_Wb9BT9o8l9sd9xZtNtVKvwO41Mh9tDWeHB1duOuX799O9v3v8hsybRNV
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZYJwEvXAaDcZuF0B5gntI4iePHCW20bJ320EnjyYovaaOuzpSkD-Xf8BP4I_wmjnMhAgbSnlrVp86pcnL8nX72dxB6FymVShqmJEx9KFBSxoiEeocEiuuQQnbktcTG5CwaXQSfL8PL9hx32e127yjJOlP3h918n_mklu93tEC8gTYDqE_8Ado8_PTl5KhLwDQK62ansJpTAnidd2TmTZP8thxt2CK9CWn-xZLWi8_xQzTt3G72nCwOVpU8UF__UHS85e96hB60YBQfNtHzGN0xdgvdnbR0-xbaO2-Erdf7eNqf0yr38R4-7yWv10_Qt7GdZzJzhD1ud4jgPMVJ4ZppWZxbvDRXiYW3MsvLtQXUWWa1yY_vpB7K1boyGPLNsu4nZmd4Dmg6t4ZkVkP4aTyHirm4zmbL9rSUxTBdIxwCo9L9nZCVczxbgesJBkNcLsCiqiOrfIoujo-mH0ekbf5AFOS8igTcN4p7cmi0YdrEUrOUB36iYykVjaShaRqF2qOUhslQJ0xRo-ATpoeRCQDEbqOBBS-fI6xoEvBIxYkH2EkOYy65ZB5jXqrcPN4O8roYEKpVRncNOq5Er-ns7pGAe-ToPy7iHfT-11euG1mQ_xm_hcASC5UJJ-btXme5WBQCSpYxlGAAmkIw2u3iTsAT7mibxJp8VYqIQY1NfXDzWROO_RU5hXIzhpEPXWiJNgWV_3bnxa2sd9G90XRyKk7HZycv0f2GTHNb8F6hQVWszGvAZJV80z6DPwFCFS_0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbYkCZe0Bi3cZuF0B5g1tI4iePHCahWYFMfVmlvVnxro65OlaQP_Tn7CfwRfhPHuRAhBhJPrepTx5KPj7-Tz_4OQu8SpayksSWxDSFBsYwRCfkOiRTXMYXoyBuJjYvL5HwWfbmOr7s6p1V_2r2nJNs7DV6lydWna21Ph4tvYchC0kj5e4og3UH3I6-TAA49C8_6UEyTuCl7Cvs6JYDceU9r3tXFbxvTjivtXZjzD7602YbG--hhhx_xWTvhj9A94w7Q3kXHkB-g42mrRb09wVfD1arqBB_j6aBSvX2Mbidukcvcc-y4O9SBC4uz0te_crhweGVuMgdfZV5UWwdAscobkx_fSdNUqG1tMISIVVMCzM3xAgBw4QyBPB88RuMFJLnlOp-vugtODkN3rdYHtEr_BiCvFni-gaFnGAxxtQSLunGG6gmajT9ffTwnXb0GoiBM1STioVE8kCOjDdMmlZpZHoWZTqVUNJGGWpvEOqCUxtlIZ0xRo-AXpkeJiQB3PkW7Dkb5HGFFs4gnKs0CgDtylHLJJQsYC6zy_QSHKOgnS6hOzNzX1LgRgwyzn18B8-sZOy7SQ_T-11_WrZLHv4zfggeIpcqF19_2n_NCLEsBWcYEsibAOTEYHfUOImBReqYlc6bYVCJhkBbTEIb5rPWb4YmcQoaYQsuH3pFEFzWqvw_nxX9ZH6G96aex-Da5_PoSPWjpL39o7hXarcuNeQ0oqpZvmpXyE06EF20
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibitory+effects+of+arbutin+on+melanin+biosynthesis+of+%CE%B1-melanocyte+stimulating+hormone-induced+hyperpigmentation+in+cultured+brownish+guinea+pig+skin+tissues&rft.jtitle=Archives+of+pharmacal+research&rft.au=Lim%2C+Yu-Ji&rft.au=Lee%2C+Eunjoo+H.&rft.au=Kang%2C+Tong+Ho&rft.au=Ha%2C+Sang+Keun&rft.date=2009-03-01&rft.pub=Pharmaceutical+Society+of+Korea&rft.issn=0253-6269&rft.eissn=1976-3786&rft.volume=32&rft.issue=3&rft.spage=367&rft.epage=373&rft_id=info:doi/10.1007%2Fs12272-009-1309-8&rft.externalDocID=10_1007_s12272_009_1309_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon